https://www.selleckchem.com/pr....oducts/emricasan-idn
nt ≈$7,500 in Vietnam). The ICER of IGC vs. SGC per ESRD event avoided was $4,559/event. The findings were robust to sensitivity analysis. Conclusion In Vietnam, gliclazide-based IGC was shown to be cost-effective compared with SGC from a healthcare payer perspective, as defined in the ADVANCE study.In Slovenia, the national SLOfit surveillance system of the somatic and motor development of children and youth has been enabling researchers to observe the developmental trends of the entire population of school-aged
Beğen
Yorum Yap
Paylaş
